Exclusive

Publication

Byline

Location

International Clinical Trial: A study to evaluate the effect of the length of gastric myotomy and the development of acid reflux after peroral endoscopic myotomy (endoscopic surgery) for esophageal motility disorders (achalasia cardia type I, II and esophagogastirc junction outlet obstruction)

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109029) titled 'A study to evaluate the effect of the length of gastric myotomy and the ... Read More


International Clinical Trial: Study of Heart Chamber Size (Left Atrial Volume) and Stroke Severity in Patients with Acute Stroke

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109033) titled 'Study of Heart Chamber Size (Left Atrial Volume) and Stroke Severity in ... Read More


International Clinical Trial: Viddhakarma, as an Ayurvedic treatment for Allergic Rhinitis, helps in complete relief from the condition

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109037) titled 'Viddhakarma, as an Ayurvedic treatment for Allergic Rhinitis, helps in c... Read More


International Clinical Trial: Motivating Core-muscle Exercises With Wearable Sensors, Haptics and Interactive Gaming

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (NCT07555795) titled 'Motivating Core-muscle Exercises With Wearable Sensors, Haptics and Interactiv... Read More


Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More


Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... Read More